Drug Report History

Return to report

Below you will find the report version history. When a report is updated, a new version of the report is created. The report history allows you to see the changes between versions. You can select two versions of the report to compare. The fields that were changed between versions will be highlighted in yellow.

The translation of reports creates two separate versions which is why some reports may not seem to have any differences. In this case, only the language field below will be highlighted in yellow.

Version v14-EN Version v8-EN
Language English English
Date Updated 2018-01-18 2018-01-03
Drug Identification Number 00550086 00550086
Brand name SEPTRA INJECTION SEPTRA INJECTION
Common or Proper name Septra® Injection Septra® Injection
Company Name ASPEN PHARMACARE CANADA INC. ASPEN PHARMACARE CANADA INC.
Ingredients SULFAMETHOXAZOLE TRIMETHOPRIM SULFAMETHOXAZOLE TRIMETHOPRIM
Strength(s) 80MG 16MG 80MG 16MG
Dosage form(s) SOLUTION SOLUTION
Route of administration INTRAVENOUS INTRAVENOUS
Packaging size 10 amps 10 amps
ATC code J01EE J01EE
ATC description SULFONAMIDES AND TRIMETHOPRIM SULFONAMIDES AND TRIMETHOPRIM
Reason for shortage Delay in shipping of the drug. Delay in shipping of the drug.
Anticipated start date
Actual start date 2017-11-20 2017-11-20
Estimated end date 2018-01-19 2018-01-12
Actual end date 2018-01-17
Shortage status Resolved Actual shortage
Tier 3 Status No No
Company comments
Health Canada comments